Cardiothoracic Surgical Trials Network Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2014
NCT02132767
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cardiothoracic Surgical Trials Network (CTSN)

Active Ingredients

Drugs in Phase 4 Trials (2)

bnt162b2 (Comirnaty) (1 trial)

mrna-1273 (Spikevax) (1 trial)

Drugs in Phase 3 Trials (3)

amiodarone (cordarone) (1 trial)

aviptadil (1 trial)

remdesivir (Veklury) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5